Pomalidomide desensitization in a patient hypersensitive to immunomodulating agents

Por Seki, J.T., Sakurai, N., Lam, W., Reece, D.E.
Publicado no Curr Oncol (2017)

Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds.

Por Seki, J, Shimada, N, Takahashi, K, Takita, T, Takeuchi, T, Hoshino, H
Publicado em 1989

Regulation and function of an activation-dependent epitope of the beta 1 integrins in vascular cells after balloon injury in baboon arteries and in vitro.

Por Koyama, N., Seki, J., Vergel, S., Mattsson, E. J., Yednock, T., Kovach, N. L., Harlan, J. M., Clowes, A. W.
Publicado em 1996

Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia

Por Sibai, H., Seki, J.T., Wang, T.Q., Sakurai, N., Atenafu, E.G., Yee, K.W.L., Schuh, A.C., Gupta, V., Minden, M.D., Schimmer, A.D., Brandwein, J.M.
Publicado no Curr Oncol (2016)

Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting

Por Seki, J.T., Sakurai, N., Moldenhauer, S., Dam, J., Atenafu, E.G., Yip, P.M., Mazzulli, T., Henderson, T., Pendergrast, J., Cserti, C., Velazquez, J.P., Simpson, R., Felluga, G., Messner, H.A., Lipton, J.H.
Publicado no Curr Oncol (2015)